Recent headlines suggest that up to 42% of people ages 55 and older face an eventual dementia diagnosis. But some experts have a follow-up message: Risk isn't the same as destiny, and there are ways ...
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for Alzheimer’s disease in 2025.